Gene-based vaccines and immunotherapeutics

Proceedings of the National Academy of Sciences of the United States of America
Margaret LiuPatrick Squiban

Abstract

DNA vaccines, comprised of plasmid DNA encoding proteins from pathogens, allergens, and tumors, are being evaluated as prophylactic vaccines and therapeutic treatments for infectious diseases, allergies, and cancer; plasmids encoding normal human proteins are likewise being tested as vaccines and treatments for autoimmune diseases. Examples of in vivo prophylaxis and immunotherapy, based on different types of immune responses (humoral and cellular), in a variety of disease models and under evaluation in early phase human clinical trials are presented. Viral vectors continue to show better levels of expression than those achieved by DNA plasmid vectors. We have focused our clinical efforts, at this time, on the use of recombinant viral vectors for both vaccine as well as cytokine gene transfer studies. We currently have four clinical programs in cancer immunotherapy. Two nonspecific immunotherapy programs are underway that apply adenoviral vectors for the transfer of cytokine genes into tumors in situ. An adenovirus-IFN gamma construct (TG1042) is currently being tested in phase II clinical trials in cutaneous lymphoma. A similar construct, adenovirus-IL2 (TG1024), also injected directly into solid tumors, is currently being tes...Continue Reading

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G Sutter, B Moss
Jan 1, 1989·Cancer Investigation·J Burchell, J Taylor-Papadimitriou
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D L BarndO J Finn
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A KnuthK H Meyer zum Büschenfelde
Sep 15, 1987·International Journal of Cancer. Journal International Du Cancer·A B GriffithsJ Taylor-Papadimitriou
Jun 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·Giao Q PhanSteven A Rosenberg
Sep 17, 2003·Journal of Biomedicine & Biotechnology·Susy SchollDavid Miles
Feb 12, 2004·Cancer Research·Howard J WajchmanKenneth E Dombrowski

❮ Previous
Next ❯

Citations

Sep 9, 2006·Cancer Immunology, Immunotherapy : CII·Teresa CabreraFederico Garrido
Dec 16, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P Mancheño-Corvo, P Martín-Duque
Jun 14, 2005·Current Opinion in Immunology·Andreas Wack, Rino Rappuoli
Feb 23, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Marinella Messina, Bruce G Robinson
Feb 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Max CorbettAlain Le Pape
Feb 16, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ming-Wei ChenChi-Huey Wong
Apr 10, 2007·DNA and Cell Biology·Raffaele Frazzi, Maurizio Zanetti
May 24, 2006·DNA and Cell Biology·Xochitl Cortez-GonzalezMaurizio Zanetti
Oct 13, 2006·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Yvonne K LentzCorinne S Lengsfeld
Jun 3, 2005·The Pediatric Infectious Disease Journal·Sharon G Humiston, Susan L Rosenthal
Aug 7, 2009·Journal of Biomechanical Engineering·Todd O PangburnEfrosini Kokkoli
Mar 4, 2006·Onkologie·Dominik RüttingerKarl-Walter Jauch
Sep 8, 2005·Microbial Cell Factories·Jacob Glenting, Stephen Wessels
May 17, 2006·PLoS Biology·Grzegorz KudlaMaciej Zylicz
Sep 22, 2006·Clinical Medicine & Research·Deanna Cross, James K Burmester
Dec 18, 2013·Indian Journal of Human Genetics·Amit BaliAshutosh Sharma
Jul 5, 2006·International Reviews of Immunology·Matthew WheelerMaurizio Zanetti
Jul 20, 2005·Expert Review of Vaccines·Scott North, Charles Butts
Feb 19, 2008·Expert Review of Anticancer Therapy·Christina S ChuGeorge Coukos
Jul 13, 2006·Expert Review of Anticancer Therapy·Rebecca A Brooks, David G Mutch
Aug 25, 2005·Expert Review of Vaccines·Bruce Acres, Jean-Marc Limacher
Oct 14, 2005·Expert Review of Vaccines·Adriana BazAnne Kelso
Apr 6, 2007·Expert Review of Vaccines·Dongmei Lu, Anthony J Hickey
Feb 1, 2008·Expert Review of Respiratory Medicine·Erin Powell, Laura Qm Chow
Mar 26, 2011·Expert Opinion on Biological Therapy·Donatella Rm NegriAndrea Cara
Aug 30, 2008·Expert Opinion on Drug Delivery·Yin Hwa Lai, Chong Wang
Aug 31, 2007·Expert Opinion on Biological Therapy·Anna KanervaAkseli Hemminki
Apr 28, 2010·Expert Opinion on Biological Therapy·Shifang YuanWei Han
May 26, 2006·Journal of Pharmaceutical Sciences·Jason RexroadC Russell Middaugh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.